Bifogade filer
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Valby, Denmark, 7 February 2024 - H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck.
+--+-----------------+--------+-------------------------------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-------------------------------+
|a)|Name |Johan Luthman |
+--+-----------------+--------+-------------------------------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-------------------------------+
|a)|Position/status |Executive Vice |
| | |President, Research |
| | |& Development |
+--+-----------------+--------+-------------------------------+
|b)|Initial |Initial notification |
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-------------------------------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-------------------------------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-------------------------------+
|b)|LEI code |5493006R4KC2OI5D3470 |
+--+-----------------+--------+-------------------------------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-------------------------------+
|a)|Description of |SharesA-shares: |
| |the financial |DK0061804697B |
| |instrument, type |-shares: |
| |of instrument |DK0061804770 |
| |Identification | |
| |code | |
+--+-----------------+--------+-------------------------------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in |
| | |accordance with long |
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-------------------------------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-------------------------------+
| | |DKK 0 |A-shares: 6,737B-shares: 26,945|
+--+-----------------+--------+-------------------------------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-------------------------------+
|e)|Date of the |2024-02-07 |
| |transaction | |
+--+-----------------+--------+-------------------------------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-------------------------------++--+-----------------+--------+-------------------------------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-------------------------------+
|a)|Name |Jacob Tolstrup |
+--+-----------------+--------+-------------------------------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-------------------------------+
|a)|Position/status |Executive Vice |
| | |President, |
| | |Commercial |
| | |Operations |
+--+-----------------+--------+-------------------------------+
|b)|Initial |Initial notification |
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-------------------------------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-------------------------------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-------------------------------+
|b)|LEI code |5493006R4KC2OI5D3470 |
+--+-----------------+--------+-------------------------------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-------------------------------+
|a)|Description of |SharesA-shares: |
| |the financial |DK0061804697B |
| |instrument, type |-shares: |
| |of instrument |DK0061804770 |
| |Identification | |
| |code | |
+--+-----------------+--------+-------------------------------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in |
| | |accordance with long |
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-------------------------------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-------------------------------+
| | |DKK 0 |A-shares: 6,396B-shares: 25,583|
+--+-----------------+--------+-------------------------------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-------------------------------+
|e)|Date of the |2024-02-07 |
| |transaction | |
+--+-----------------+--------+-------------------------------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-------------------------------++--+-----------------+--------+-------------------------------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-------------------------------+
|a)|Name |Keld Flintholm |
| | |Jørgensen |
+--+-----------------+--------+-------------------------------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-------------------------------+
|a)|Position/status |Executive Vice |
| | |President, Corporate |
| | |Strategy & Business |
| | |Development |
+--+-----------------+--------+-------------------------------+
|b)|Initial |Initial notification |
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-------------------------------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-------------------------------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-------------------------------+
|b)|LEI code |5493006R4KC2OI5D3470 |
+--+-----------------+--------+-------------------------------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-------------------------------+
|a)|Description of |SharesA-shares: |
| |the financial |DK0061804697B |
| |instrument, type |-shares: |
| |of instrument |DK0061804770 |
| |Identification | |
| |code | |
+--+-----------------+--------+-------------------------------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in |
| | |accordance with long |
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-------------------------------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-------------------------------+
| | |DKK 0 |A-shares: 4,913B-shares: 19,649|
+--+-----------------+--------+-------------------------------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-------------------------------+
|e)|Date of the |2024-02-07 |
| |transaction | |
+--+-----------------+--------+-------------------------------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-------------------------------++--+-----------------+--------+-------------------------------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-------------------------------+
|a)|Name |Lars Bang |
+--+-----------------+--------+-------------------------------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-------------------------------+
|a)|Position/status |Executive Vice |
| | |President, Product |
| | |Development & Supply |
+--+-----------------+--------+-------------------------------+
|b)|Initial |Initial notification |
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-------------------------------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-------------------------------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-------------------------------+
|b)|LEI code |5493006R4KC2OI5D3470 |
+--+-----------------+--------+-------------------------------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-------------------------------+
|a)|Description of |SharesA-shares: |
| |the financial |DK0061804697B |
| |instrument, type |-shares: |
| |of instrument |DK0061804770 |
| |Identification | |
| |code | |
+--+-----------------+--------+-------------------------------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in |
| | |accordance with long |
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-------------------------------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-------------------------------+
| | |DKK 0 |A-shares: 6,626B-shares: 26,504|
+--+-----------------+--------+-------------------------------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-------------------------------+
|e)|Date of the |2024-02-07 |
| |transaction | |
+--+-----------------+--------+-------------------------------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-------------------------------+Persons under an obligation to report are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.
Closely associated persons/entities means inter alia:
- spouse or cohabitant
- dependent children
- legal entities in which the executive has a controlling influence
Lundbeck contacts
Investors: Media:
Palle Holm Olesen Thomas Mikkel
Mortensen
Vice President, Investor Relations Media Relations Lead,
Corporate
Communication
PALO@lundbeck.com THMR@lundbeck.com
+45 30 83 24 26 +45 30 83 30 24
Sophia Nørskov Bech
Senior Manager, Investor Relations
SONQ@lundbeck.com
+45 30 83 24 60
About H. Lundbeck A/S
Lundbeck is a biopharmaceutical company focused exclusively on neuroscience, with more than 70 years of experience in improving the lives of people with neurological and psychiatric diseases. As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options. Our goal is to create long term value and make a positive contribution to people and societies, everywhere we operate. We are committed to fighting stigma and discrimination, and we act to improve health equity for the people we
serve and the communities we are part of.
For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us via LinkedIn.